Search Result "KRAS mutation."


Selumetinib in Advanced Non Small Cell Lung Cancer (NSCLC) Harbouring KRAS Mutation: Endless Clinical Challenge to KRAS-mutant NSCLC.

Journal: Reviews on Recent Clinical Trials
Volume: 8 Issue: 2 Year: 2013 Page: 93-100
Author(s): Paolo Maione,Assunta Sgambato,Antonio Rossi,Paola Claudia Sacco,Maria Anna Bareschino,Clorinda Schettino,Francesca Casaluce,Fortunato Ciardiello,Cesare Gridelli

Cetuximab/Irinotecan-Chemotherapy in KRAS Wild-type Pretreated Metastatic Colorectal Cancer: A Pooled Analysis and Review of Literature.

Journal: Reviews on Recent Clinical Trials
Volume: 8 Issue: 2 Year: 2013 Page: 101-109
Author(s): Sandro Barni,Mara Ghilardi,Karen Borgonovo,Mary Cabiddu,Alberto Zaniboni,Fausto Petrelli

Mutations in MicroRNA Genes and Their Binding Sites are Infrequently Associated with Human Colorectal Cancer in the Kashmiri Population

Journal: MicroRNA
Volume: 2 Issue: 3 Year: 2013 Page: 219-224
Author(s): Raihana Maqbool,Rehana Ismail,Mahboob- ul- Hussain

Tumour Mutation Profiling with High-throughput Multiplexed Genotyping: A Review of its Use for Guiding Targeted Cancer Therapy

Journal: Current Cancer Therapy Reviews
Volume: 9 Issue: 4 Year: 2013 Page: 236-244
Author(s): Mark J. McKeage,Phillip Shepherd,Masato Yozu,Donald R. Love

MicroRNA Involvement in Gastrointestinal Stromal Tumor Tumorigenesis

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 7 Year: 2013 Page: 1227-1235
Author(s): Won Kyu Kim,Han-Kwang Yang,Hoguen Kim

BRCA2 Dysfunction Promotes Malignant Transformation of Pancreatic Intraepithelial Neoplasia

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13 Issue: 2 Year: 2013 Page: 261-269
Author(s): Qi Wang,Hongrui Liu,Tingting liu,Shizhen Shu,He Jiang,Shidan Cheng,Yaozong Yuan,Weiguo Yang,Lifu Wang

Unmet Needs in Ovarian Cancer: Dividing Histologic Subtypes to Exploit Novel Targets and Pathways

Journal: Current Cancer Drug Targets
Volume: 13 Issue: 6 Year: 2013 Page: 698-707
Author(s): Vijaya Galic,Robert L. Coleman,Thomas J. Herzog

Membrane Tyrosine Kinase Receptors Kit and FLT3 are an Important Targets for the Therapy of Acute Myeloid Leukemia

Journal: Current Cancer Therapy Reviews
Volume: 9 Issue: 3 Year: 2013 Page: 181-219
Author(s): Ugo Testa

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Current Status and Future Perspectives in the Development of Novel Irreversible Inhibitors for the Treatment of Mutant Non-small Cell Lung Cancer

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 5 Year: 2013 Page: 818-832
Author(s): Elena Galvani,Roberta Alfieri,Elisa Giovannetti,Andrea Cavazzoni,Silvia La Monica,Maricla Galetti,Claudia Fumarola,Mara Bonelli,Marco Mor,Marcello Tiseo,Godefridus J. Peters,Pier Giorgio Petronini,Andrea Ardizzoni

Extracellular Superoxide and the Growth of Pancreatic Carcinoma

Journal: Current Cancer Therapy Reviews
Volume: 9 Issue: 4 Year: 2013 Page: 278-283
Author(s): John A. Cieslak,Joseph J. Cullen

Previous   Next

Go To   Results 1 - 1 of 87

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy